Biofrontera INC. (BFRIW) SEC Filings — 2025
25 SEC filings for Biofrontera INC. (BFRIW) in 2025.
Filings
- Biofrontera Resale Offering Signals Strategic Shift, Ameluz® Rights Acquired — S-1 · Dec 5, 2025
- Biofrontera INC. 8-K Filing — 8-K · Nov 13, 2025
- Biofrontera's Losses Widen Amid Strategic Shift, Liquidity Concerns — 10-Q · Nov 12, 2025
- Biofrontera INC. 8-K Filing — 8-K · Nov 10, 2025
- Biofrontera Inc. Files 8-K with Key Agreements and Acquisitions — 8-K · Nov 7, 2025
- Biofrontera Inc. Completes Acquisition, Reports Equity Sales — 8-K · Oct 24, 2025
- Biofrontera Inc. Files 8-K with Regulatory Disclosures — 8-K · Oct 23, 2025
- Biofrontera Inc. Files 8-K on Shareholder Vote Matters — 8-K · Sep 19, 2025
- Biofrontera Amends Ameluz Deal, Boosts Dosage, Divests Xepi — S-1/A · Aug 13, 2025
- Biofrontera Inc. Files 8-K: Director, Officer, and Compensation Updates — 8-K · Aug 11, 2025
- Biofrontera Seeks Reverse Split, Series C Conversion Approval — DEF 14A · Aug 5, 2025
- Biofrontera Files S-1 for Continuous Offering, Signaling Capital Raise — S-1 · Jul 16, 2025
- Biofrontera Inc. Files 8-K with Key Corporate Updates — 8-K · Jul 1, 2025
- Biofrontera Inc. Files 8-K with Financial Updates — 8-K · Jun 30, 2025
- Biofrontera Inc. Files 8-K on Shareholder Votes — 8-K · Jun 18, 2025
- Biofrontera Inc. Files 8-K Report — 8-K · Jun 11, 2025
- Biofrontera Inc. Files 8-K Report — 8-K · Jun 3, 2025
- Biofrontera Inc. Faces Delisting Concerns — 8-K · May 23, 2025
- Biofrontera Inc. Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Biofrontera Inc. Faces Delisting Concerns — 8-K · May 14, 2025
- Biofrontera Inc. Files Definitive Proxy Statement — DEF 14A · Apr 30, 2025
- Biofrontera Inc. Changes Certifying Accountant — 8-K · Apr 18, 2025
- Biofrontera Inc. Files 8-K on Financials — 8-K · Mar 21, 2025
- Biofrontera Inc. Files 2024 10-K — 10-K · Mar 20, 2025
- Biofrontera Inc. Files S-1 with SEC — S-1 · Jan 17, 2025